MARATTO

article · Applied immunohistochemistry & molecular morphology

Clinicopathological Impact of FOXM1 and MMP-9 Immunohistochemical Expression in Different Grades of Intracranial Meningioma

Abstract

Strong FOXM1, strong MMP-9, and high Ki67 in meningiomas indicate highly aggressive tumors with a shortened survival rate, dismal outcome, and high risk of recurrence after the standard protocol of therapy.

Research topics

  • Meningioma and schwannoma management
  • Glioma Diagnosis and Treatment
  • Neurofibromatosis and Schwannoma Cases

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1097/pai.0000000000001205

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.